Enorama Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ERMA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders601,8991.47%
Institutions1,016,6852.48%
General Public17,048,10341.7%
Private Companies22,258,65754.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 337.6%.


Top Shareholders

Top 9 shareholders own 58.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.9%
Dharampal Satyapal Limited
7,715,073kr22.9m0%no data
18.4%
Swede Unipharma AB
7,543,584kr22.4m0%no data
17.1%
RD Global General Trading L.L.C
7,000,000kr20.8m0%no data
2.25%
Avanza Fonder AB
919,760kr2.7m0%0.01%
0.47%
Kerstin Monsén
190,860kr566.9k0%no data
0.43%
Fredrik Olsson
176,000kr522.7k0%no data
0.31%
Ewa Ericson
125,600kr373.0k0%no data
0.27%
Fredrik Fagerberg
109,439kr325.0k0%no data
0.24%
Swedbank Försäkring AB, Asset Management Arm
96,925kr287.9k0%0.06%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.